Subscribe to Free Daily Newsletters
Post a Job

Featured Jobs

Executive Director

Employers Council on Flexible Compensation (ECFC)
(Washington DC / Telecommute)
MEP Assistant Team Leader

Nova 401(k) Associates
(Houston TX / Dallas TX / Austin TX / Scottsdale AZ / Telecommute)
Employee Benefits (ERISA) Associate Attorney

Stinson LLP
(Kansas City MO / Minneapolis MN)
Senior Retirement Plan Administrator

RetireWell Administrators, Inc.
(Marlton NJ / Telecommute)
401(k) Plan Administrator
Southern Pension Services
(Tampa FL)

Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Get the BenefitsLink app LinkedIn
Twitter
Facebook
Webcasts  >  Upcoming, by Date   |   Recorded
Conferences  >  Upcoming, by Date   |   Upcoming, by State
Combined  >  Upcoming, by Date   |   Recorded or Upcoming, by Sponsor

View More Manatt Webcasts and Conferences

Drug Pricing Transparency Rule: What You Need to Know

Manatt

June 25, 2019
Recorded Online
Webcast

On May 8, 2019, the administration issued the much-anticipated final rule requiring drug manufacturers to disclose wholesale acquisition prices in their broadcast advertising. The debate around the rule has been raging since October, when the proposal was first published. Set to go into effect on July 9, the rule could have a major impact on how life sciences companies promote to their customers. With both strong supporters and vocal opponents, it also could face a myriad of legal challenges in the months ahead.

In a new on-demand webinar, Manatt Health describes the new rule and its potential impact.

Speakers:

  • Alexander Dworkowitz, Manatt Health
  • Jeremy A. Lutsky, Manatt Health
  • Ian Spatz, Manatt Health

Continue by clicking on the following link:
https://www.manatt.com/Insights/Newsletters/Health-Update/The-Final-Rules-Impact-on-Drug-Pricing-Transparenc

© 2019 BenefitsLink.com, Inc.